Training on GLP-1 Medications: How to Preserve Muscle and Maximize Your Results

Nearly one in eight American adults has tried a GLP-1 medication like Ozempic, Wegovy, or Mounjaro¹. The drugs work — often dramatically. People are losing 15–25% of their body weight in clinical trials, numbers that were previously only achievable through bariatric surgery². But there’s a problem hiding inside those impressive results, and it’s one that most people on these medications don’t discover until they’ve already lost something they didn’t intend to: their muscle.

In the landmark STEP 1 trial, semaglutide produced an average weight loss of 14.9% over 68 weeks. But body composition analysis revealed that approximately 39% of the total weight lost was lean body mass — not fat³. That’s not a rounding error. For someone who loses 40 pounds, that could mean roughly 15 pounds of muscle tissue gone along with the fat. And muscle, unlike fat, is what keeps your metabolism running, your bones protected, your balance steady, and your body functional as you age.

The good news? This doesn’t have to happen. A growing body of research — including a major study published just this month in Cell Reports Medicine⁴ — shows that the right exercise strategy can dramatically shift the ratio of what you lose. The key is understanding what GLP-1 medications do to your body, why muscle loss occurs, and how to train specifically to counteract it.

What GLP-1 Medications Actually Do

GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) — mimic a natural gut hormone called glucagon-like peptide-1. When you eat, your body releases GLP-1 to signal fullness, slow gastric emptying, and regulate blood sugar. These drugs amplify that signal, creating a persistent feeling of satiety that makes it far easier to eat less⁵.

The result is a significant caloric deficit, often without the white-knuckle hunger that derails most diets. But here’s the catch: your body doesn’t distinguish between “intentional caloric deficit for health” and “famine.” When calories drop substantially, the body’s survival mechanisms kick in. It doesn’t just burn stored fat — it breaks down muscle tissue for amino acids and energy. This is especially true when exercise isn’t part of the equation⁶.

A 2025 systematic review found that across semaglutide trials, lean mass loss ranged from 26% to 40% of total weight lost⁶. For tirzepatide, the numbers were similar. The review’s authors noted that without a deliberate intervention — namely resistance training and adequate protein — muscle loss is essentially built into the pharmacological weight loss process.

The March 2026 Study That Changed the Narrative

On March 17, 2026, a research team led by Langer et al. published a study in Cell Reports Medicine that reframed the muscle loss conversation⁴. Using four preclinical models in mice, they found that GLP-1 receptor agonists did reduce absolute muscle mass — but the loss was proportional to overall weight loss, not disproportionate. More strikingly, the mice on GLP-1 medications showed improved relative muscle mass (muscle as a percentage of body weight) and actually performed better on running endurance tests than control animals.

The study also included human data, comparing body composition changes in GLP-1-treated patients to those seen with caloric restriction alone. The conclusion: GLP-1 medicines affect muscle differently than simple caloric restriction, with evidence of preserved muscle quality even when absolute mass decreases modestly⁴.

This doesn’t mean muscle loss isn’t a concern — it absolutely is, especially for people who aren’t exercising. But it does suggest that the “Ozempic melts your muscles” narrative is more nuanced than headlines suggest. The real risk isn’t the medication itself — it’s what you do (or don’t do) alongside it.

Why Muscle Matters More Than the Scale

Before diving into the training strategy, it’s worth understanding why losing muscle is such a big deal — even when the scale is moving in the right direction.

Metabolic rate. Muscle tissue is metabolically active. Each kilogram of skeletal muscle burns roughly 10–13 calories per day at rest⁷. Lose five kilograms of muscle during a weight loss phase, and your resting metabolic rate drops by 50–65 calories daily. That doesn’t sound like much, but over a year it compounds — and it’s one reason weight regain is so common after stopping GLP-1 medications.

Functional strength. Muscle is what lets you carry groceries, climb stairs, play with your kids, and get off the floor without assistance as you age. The SEMALEAN study, published in late 2025, found that semaglutide-treated patients who maintained their lean mass also preserved muscle function — grip strength, chair-stand performance, and gait speed — better than those who lost significant lean tissue⁸.

Bone health. Muscle and bone are intimately connected. Muscles pull on bones during contraction, providing the mechanical stimulus that maintains bone density. Rapid weight loss without resistance training has been associated with accelerated bone mineral density loss — a serious concern for anyone over 40⁹.

Long-term weight maintenance. A 2026 study in Fox News Health reported that stopping GLP-1 drugs erases cardiovascular benefits within two years, with risk increasing by 22%¹⁰. Muscle mass is your insurance policy. The more metabolically active tissue you carry, the more resilient your metabolism is when (or if) you come off the medication.

The Training Protocol: What the Science Supports

Here’s the actionable framework. If you’re on a GLP-1 medication (or considering one), this is how to structure your training to preserve muscle, maintain strength, and get the most from your weight loss.

1. Resistance Training Is Non-Negotiable

This is the single most important intervention. A 2025 review in Frontiers in Clinical Diabetes and Healthcare found that combining GLP-1 medications with structured resistance training preserved significantly more lean mass than medication alone¹¹. The review concluded that exercise — particularly resistance exercise — should be considered an essential co-therapy, not an optional add-on.

What to do: Aim for two to four resistance training sessions per week, each lasting 30–45 minutes. Focus on compound movements that load multiple muscle groups simultaneously — squats, deadlifts, presses, rows, lunges, and carries. These movements provide the most muscle-preserving stimulus per unit of time.

How heavy: Work in the 6–15 repetition range with loads heavy enough that the last two to three reps of each set feel genuinely challenging. You don’t need to train to absolute failure, but you do need to be within a few reps of it. Progressive overload — gradually increasing weight or reps over weeks — is essential.

2. Prioritize Protein Like Your Muscles Depend on It (They Do)

GLP-1 medications suppress appetite, which is the point — but it also means many people drastically under-eat protein. A 2025 expert panel recommended that people on GLP-1 medications consume 1.2 to 1.6 grams of protein per kilogram of body weight daily, with some recommending up to 2.0 g/kg for those actively resistance training¹². For a 180-pound person, that’s roughly 100–145 grams of protein per day.

Practical tips:

Prioritize protein at every meal. When your appetite is reduced, make protein the first thing on your plate before filling up on other foods.
Consider protein supplementation. Whey or plant-based protein shakes can help you hit targets when solid food feels unappealing.
Spread intake across the day. Research suggests distributing protein across three to four meals (25–40 grams each) optimizes muscle protein synthesis better than loading it into one or two meals¹².

3. Don’t Skip Cardio — But Don’t Overdo It

Aerobic exercise supports cardiovascular health, mood, and overall metabolic function. But excessive cardio on top of the caloric deficit created by GLP-1 medications can accelerate muscle loss. The sweet spot appears to be two to three moderate-intensity cardio sessions per week — brisk walking, cycling, swimming — lasting 20–40 minutes each.

If you’re already a runner or endurance athlete, you don’t need to stop. But be aware that your recovery needs have changed. The caloric deficit from GLP-1 medication means your body has fewer resources available for repair. Listen to your body, and consider scaling back intensity or volume during periods when the medication’s appetite suppression is strongest.

4. Monitor Recovery, Not Just Output

This is where most generic fitness programs fall short for GLP-1 users. Your body is in a sustained caloric deficit — even if you’re not actively trying to restrict food. That deficit affects recovery capacity, sleep quality, energy levels, and training readiness. A workout plan that was perfectly appropriate before starting medication may now be too much volume or too high intensity.

Signs you need to pull back:

Persistent fatigue that doesn’t resolve with rest
Strength going down instead of up over consecutive weeks
Elevated resting heart rate or suppressed HRV
Increased joint or tendon soreness
Poor sleep quality despite consistent habits

Wearable devices that track heart rate variability, resting heart rate, and sleep stages can provide objective data to guide these decisions. Instead of guessing whether today is a “push hard” or “take it easy” day, you can use biometric signals to adjust in real time.

5. Train for the Long Game

GLP-1 medications are typically prescribed for months to years. That means your training program needs to be sustainable, not heroic. The biggest mistake people make is treating the weight loss phase like a crash diet with a matching crash exercise program — six days a week, high intensity, minimal rest. That approach burns out your body and your motivation.

A realistic, sustainable schedule for most GLP-1 users:

Day	Focus
Monday	Upper body resistance (push/pull)
Tuesday	30 min moderate cardio or active recovery
Wednesday	Lower body resistance
Thursday	Rest or light walking
Friday	Full body resistance
Saturday	Recreational activity (hiking, sports, yoga)
Sunday	Rest

Adjust this template based on your recovery data, your energy levels, and how your body responds week to week.

Where AI Meets GLP-1 Training

Here’s the reality: the optimal training approach for someone on a GLP-1 medication changes constantly. Your appetite fluctuates with dose titration. Your energy levels shift as your body adapts. Your recovery needs evolve as you lose weight and your body composition changes. A static program written on day one won’t be right on day sixty.

This is exactly the kind of problem that AI — specifically, an LLM with access to your personal health data — is uniquely positioned to solve. When an AI coach like SensAI can see your daily HRV trends from your Apple Watch, your sleep staging from your Oura ring, your resting heart rate patterns, and your training history, it can make informed decisions about when to push, when to pull back, and how to adjust your program as your GLP-1 journey unfolds.

It’s the difference between following a generic “GLP-1 workout plan” from the internet and having a coach that understands your body, your data, and your recovery capacity — every single day.

The Bottom Line

GLP-1 medications are a powerful tool for weight loss. But a tool is only as good as how you use it. Without deliberate exercise and nutrition strategies, you risk losing the very tissue — muscle — that determines your metabolic health, functional capacity, and long-term weight maintenance.

The formula isn’t complicated:

Lift weights two to four times per week, focusing on compound movements with progressive overload.
Eat enough protein — 1.2 to 1.6 g/kg minimum, ideally spread across the day.
Keep cardio moderate — enough for cardiovascular health, not so much that it accelerates muscle loss.
Monitor recovery using wearable data and adjust training when your body signals it needs rest.
Think in months, not weeks. Sustainable consistency beats short-term intensity every time.

The scale will move. The question is what you’ll have left when it stops. Train smart, fuel well, and let your data guide the way — and you’ll come out the other side not just lighter, but stronger.

References

KFF. “KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs.” Kaiser Family Foundation, 2024. https://www.kff.org/health-costs/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs/ ↩
Wilding, J.P.H. et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” New England Journal of Medicine, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 ↩
Kosiborod, M.N. et al. “Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity.” Journal of the Endocrine Society, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8089287/ ↩
Langer, H. et al. “Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans.” Cell Reports Medicine, March 17, 2026. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00082-0 ↩ ↩² ↩³
Drucker, D.J. “Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.” Cell Metabolism, 2018. https://pubmed.ncbi.nlm.nih.gov/30421364/ ↩
Nunn, E. et al. “Preservation of lean soft tissue during weight loss induced by GLP-1 receptor agonists.” Diabetes, Obesity and Metabolism, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12536186/ ↩ ↩²
Westcott, W.L. “Resistance Training is Medicine: Effects of Strength Training on Health.” Current Sports Medicine Reports, 2012. https://pubmed.ncbi.nlm.nih.gov/22777429/ ↩
Alissou, M. et al. “Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study.” Diabetes, Obesity and Metabolism, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12673431/ ↩
Villareal, D.T. et al. “Bone Mineral Density Response to Caloric Restriction–Induced Weight Loss or Exercise-Induced Weight Loss.” Archives of Internal Medicine, 2006. https://pubmed.ncbi.nlm.nih.gov/17130388/ ↩
Fox News Health. “Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds.” Fox News, March 24, 2026. https://www.foxnews.com/health/stopping-glp-1-drugs-like-ozempic-erodes-heart-health-benefits-quickly ↩
Sargeant, J.A. et al. “GLP-1 agonists and exercise: the future of lifestyle prioritization in cardiometabolic medicine.” Frontiers in Clinical Diabetes and Healthcare, November 2025. https://www.frontiersin.org/journals/clinical-diabetes-and-healthcare/articles/10.3389/fcdhc.2025.1504209/full ↩
SELF Magazine. “Here’s Exactly How Much Protein to Eat If You’re on a GLP-1.” SELF, October 2025. https://www.self.com/story/how-much-protein-eat-glp-1-drug ↩ ↩²